Interaction of Osteopontin with IL-18 in Obese Individuals: Implications for Insulin Resistance

Osteopontin Is an Activator of Human Adipose Tissue Macrophages and Directly Affects Adipocyte Function

(2011) Maximilian Zeyda et al.   ENDOCRINOLOGY

Adipose Tissue, Inflammation and Atherosclerosis

(2011) Birgit Gustafson   Journal of Atherosclerosis and Thrombosis

NF- B- and AP-1-Mediated DNA Looping Regulates Osteopontin Transcription in Endotoxin-Stimulated Murine Macrophages

(2011) W. Zhao et al.   JOURNAL OF IMMUNOLOGY

Lean Body Mass, Interleukin 18, and Metabolic Syndrome in Apparently Healthy Chinese

(2011) Liang Sun et al.   PLoS One

Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-κB activation

(2010) Venkatapuram Seenu Reddy et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Neutralization of Osteopontin Inhibits Obesity-Induced Inflammation and Insulin Resistance

(2010) F. W. Kiefer et al.   DIABETES

IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice

(2009) Qianli Yu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The major inflammatory mediator interleukin-6 and obesity

(2009) Katalin Eder et al.   INFLAMMATION RESEARCH

Osteopontin Enhances Phagocytosis through a Novel Osteopontin Receptor, the  X 2 Integrin

(2009) L. Schack et al.   JOURNAL OF IMMUNOLOGY

Elevated Expression of Osteopontin May Be Related to Adipose Tissue Macrophage Accumulation and Liver Steatosis in Morbid Obesity

(2008) A. Bertola et al.   DIABETES